Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-19 Sale |
2022-01-21 4:54 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
6,700 | $21.21 | $142,080 | 168,784 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 4:47 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
4,168 | $23.29 | $97,073 | 128,875 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-06 4:37 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
7,168 | $28.02 | $200,847 | 133,043 (Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 7:19 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $27.95 | $83,852 | 140,211 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 4:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $24.14 | $136,826 | 143,211 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-03 4:36 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $27.38 | $155,190 | 148,879 (Direct) |
View |
| 2021-11-15 Sale |
2021-11-17 5:01 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
7,168 | $27.01 | $193,574 | 154,547 (Direct) |
View |
| 2021-11-05 Sale |
2021-11-09 5:44 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
16,500 | $28.06 | $463,041 | 161,715 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:57 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
5,668 | $24.79 | $140,510 | 178,215 (Direct) |
View |
| 2021-11-01 Sale |
2021-11-03 4:55 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $25.5 | $228,327 | 24,628 (Direct) |
View |
| 2021-10-27 Sale |
2021-10-28 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
3,000 | $24 | $71,991 | 183,883 (Direct) |
View |
| 2021-10-21 Sale |
2021-10-25 4:28 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
1,042 | $21.1 | $21,984 | 186,883 (Direct) |
View |
| 2021-10-25 Purchase |
2021-10-25 2:47 pm |
Crinetics Pharmaceuticals Inc. | CRNX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,200,000 | $19.8 | $23,760,000 | 5,163,517 (Indirect) |
View |
| 2021-09-08 Sale |
2021-09-09 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $25.5 | $154,173 | 33,582 (Direct) |
View |
| 2021-09-07 Sale |
2021-09-09 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
30,000 | $25 | $750,000 | 985,805 (Indirect Direct) |
View |
| 2021-07-26 Sale |
2021-07-27 8:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $19.59 | $97,950 | 39,628 (Direct) |
View |
| 2021-07-19 Sale |
2021-07-20 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $19.5 | $97,500 | 44,628 (Direct) |
View |
| 2021-07-12 Sale |
2021-07-13 5:00 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $20.71 | $103,550 | 49,628 (Direct) |
View |
| 2021-04-08 Purchase |
2021-04-09 09:00 am |
Crinetics Pharmaceuticals Inc. | CRNX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
304,136 | $16.44 | $4,999,996 | 3,963,517 (Indirect) |
View |
| 2020-12-02 Purchase |
2020-12-04 4:59 pm |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
5,000 | $13 | $65,000 | 1,195,805 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-19 Exercise |
2022-01-21 4:54 pm |
N/A 2028-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
6,700 | $0 | 168,784 (Direct) |
View |
| 2022-01-19 Exercise |
2022-01-21 4:54 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
6,700 | $12.01 | 168,784 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-10 4:34 pm |
N/A 2031-12-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:55 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $0 | 24,628 (Direct) |
View |
| 2021-11-01 Exercise |
2021-11-03 4:55 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
8,954 | $1.91 | 24,628 (Direct) |
View |
| 2021-10-28 Exercise |
2021-11-01 7:11 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
106,383 | $0.73 | 184,671 (Direct) |
View |
| 2021-10-28 Exercise |
2021-11-01 7:11 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
106,383 | $0 | 184,671 (Direct) |
View |
Ownership |
2021-10-19 4:54 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer |
0 | $0 | 677,730 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $0 | 33,582 (Direct) |
View |
| 2021-09-08 Exercise |
2021-09-09 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
6,046 | $1.91 | 33,582 (Direct) |
View |
| 2021-09-01 Option Award |
2021-09-02 5:05 pm |
N/A 2031-08-30 |
Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-27 8:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 39,628 (Direct) |
View |
| 2021-07-26 Exercise |
2021-07-27 8:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 39,628 (Direct) |
View |
| 2021-07-19 Exercise |
2021-07-20 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 44,628 (Direct) |
View |
| 2021-07-19 Exercise |
2021-07-20 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 44,628 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 5:00 pm |
N/A 2028-03-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $0 | 49,628 (Direct) |
View |
| 2021-07-12 Exercise |
2021-07-13 5:00 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
5,000 | $1.91 | 49,628 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDALL Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:27 pm |
N/A 2031-02-25 |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:25 pm |
N/A 2031-02-25 |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
131,000 | $0 | 131,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:23 pm |
N/A 2031-02-25 |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO and Secretary |
114,000 | $0 | 114,000 (Direct) |
View |
| 2021-02-26 Option Award |
2021-03-02 5:21 pm |
N/A 2031-02-25 |
Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO |
294,000 | $0 | 294,000 (Direct) |
View |
| 2020-05-20 Ownership |
2021-02-05 4:48 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Madan Ajay Chief Development Officer |
1,470 | $14.45 | 78,986 (Direct) |
View |
| 2020-05-20 Ownership |
2021-02-05 4:46 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
1,165 | $14.45 | 7,825 (Direct) |
View |
| 2020-11-20 Ownership |
2021-02-05 4:46 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Krasner Alan Seth Chief Medical Officer |
277 | $11.61 | 7,825 (Direct) |
View |
| 2020-05-20 Ownership |
2021-02-05 4:43 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO and Secretary |
697 | $14.45 | 61,590 (Direct) |
View |
| 2020-11-20 Ownership |
2021-02-05 4:43 pm |
N/A N/A |
Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO and Secretary |
702 | $11.61 | 61,590 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 5:58 pm |
N/A 2030-08-31 |
Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director |
25,000 | $0 | 25,000 (Direct) |
View |